Quality of care for secondary cardiovascular disease prevention in 2009–2017: population-wide cohort study of antiplatelet therapy use in Scotland

BACKGROUND: Antiplatelet therapy (APT) can substantially reduce the risk of further vascular events in individuals with established atherosclerotic cardiovascular disease (ASCVD). However, knowledge regarding the extent and determinants of APT use is limited. OBJECTIVES: Estimate the extent and iden...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Qual Saf
Main Authors: Thalmann, Inna, Preiss, David, Schlackow, Iryna, Gray, Alastair, Mihaylova, Borislava
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2023
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616486/
https://ncbi.nlm.nih.gov/pubmed/37775268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjqs-2023-016520
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados